Indefinite Delivery Contract 36E79725D0019

Award Date 5/14/25
Last Date to Order 5/13/26
Awardee
Avkare LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The contract, valued at $11,322,584.10, is for the supply of Aspirin 25mg/Dipyridamole 200mg capsules to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The period of performance is one base year from April 6, 2020 to April 5, 2021, with four...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee. The contract, valued at $4,619,331.60, is for the supply of phenytoin sodium extended-release capsules to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a one-year base period with four one-year option periods, and allows the...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency under the Department of Veterans Affairs (VA), to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $29,293,343.30 and a period of performance from August 30, 2021 to August 29, 2025, with four one-year option periods. The contract is for the supply of venlafaxine hydrochloride extended-release capsules in various...
This Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC is for the supply of Acetazolamide Tablets in 125mg and 250mg strengths. The contract has a ceiling value of $2,075,624.60 and a period of performance from July 31, 2022 to July 30, 2023, with four one-year option periods. The contract supports the procurement needs of the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS)...
This single-award Indefinite Delivery Contract (IDC) was issued by the National Acquisition Center, a civilian agency of the U.S. Department of Veterans Affairs (VA), to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $11.95 million contract has a 1-year ordering period from 12/11/2022 to 12/10/2023, with four 1-year option periods, for a total potential period of performance through 12/10/2025. The contract is to provide an uninterrupted supply of Acitretin...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The single-award, $1,099,043 contract provides for the supply of Verapamil IR tablets to the VA, Bureau of Prisons (BOP), and Indian Health Service (IHS) over a base year from June 1, 2020 to May 31, 2021, with four one-year option periods. The contract was competed as an unrestricted...
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Avkare, LLC on October 1, 2019 to procure dofetilide capsules. The contract has a potential value of $7,634,774.75 over a one-year base period and four one-year option periods through September 30, 2024. The original solicitation sought to establish an unrestricted contract vehicle for an uninterrupted supply of dofetilide capsules to support the VA's pharmaceutical prime...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Avkare, LLC on February 24, 2019 for the potential value of $4,776,987.75. The contract provides for acyclovir capsules over a base year and four one-year option periods ending February 23, 2024. No set-aside provisions were applied. Under the contract, the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 issued a $478,966...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Avkare, LLC on February 23, 2019. The contract has a potential value of $2.29M and a period of performance from February 23, 2019 through February 22, 2024, consisting of a base year and four option years. Under the contract, Avkare will supply tenofovir disoproxil fumarate tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through their...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The contract has a ceiling value of $1,146,440.00 and a period of performance from August 12, 2021, to August 11, 2025, with four one-year option periods. The contract is for the supply of Piroxicam capsules, a generic...

The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The $9,005,168.25 contract is for the delivery of Aspirin 25 MG/Dipyridamole 200MG Sustained Action (SA) Capsules to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a one-year base period from May 14, 2025 to May 13, 2026, with four one-year option periods. Avkare will supply the pharmaceutical products through the VA's and DoD's Pharmaceutical Prime Vendor Programs.

The original solicitation, RFP 36E79724R0034, was issued by the VA National Acquisition Center in commercial item format under NAICS code 325412. The procurement was unrestricted, with no small business set-asides. The estimated annual usage is 37,545 bottles of 60-count capsules. Offerors were required to provide a unique National Drug Code (NDC) or Universal Product Code (UPC) for the exact drug name appearing on the product label. The packaging specifications include a cylindrical bottle with a minimum 5.75-inch circumference and a label dimension of 5.25 x 2 inches, with an additional 0.5 inch to expose the barcode and/or display the expiration date and lot number. Glass bottles are not acceptable.

Generated 3/15/25, 9:48 AM